Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned?

Xin Zhang1, Maité Rielland, Safak Yalcin

  • 1Department of Development and Regenerative Biology, Mount Sinai School of Medicine, New York, NY 10029, USA.

Current Drug Targets
|March 30, 2011
PubMed

Insights

Forkhead box proteins (FoxOs) regulate cell responses to DNA damage and oxidative stress, impacting stem cell maintenance. Their dual role as tumor suppressors and leukemic stem cell regulators highlights the need for understanding their complex functions.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Forkhead box (FoxO) transcription factors are crucial for cellular responses to genotoxic and oxidative stress.
  • FoxOs regulate cell cycle arrest, DNA repair, and apoptosis, and are vital for maintaining hematopoietic stem and progenitor cells.
  • While generally acting as tumor suppressors, FoxOs are increasingly recognized for their role in supporting leukemic stem cells.

Purpose of the Study:

  • To review recent advancements in understanding FoxO function in normal and cancer stem cells.
  • To explore the regulatory mechanisms governing FoxO expression and activity in various cell types and tissues.
  • To discuss the implications of FoxO regulation for therapeutic strategies in cancer and other diseases.

Main Methods:

  • Literature review of recent studies on FoxO transcription factors.
  • Analysis of FoxO roles in normal stem cells (e.g., hematopoietic) and cancer stem cells.
  • Examination of regulatory networks controlling FoxO expression and activity.

Main Results:

  • FoxOs play critical roles in stem cell regulation, particularly in the hematopoietic system, by modulating antioxidant defenses.
  • Evidence suggests FoxOs function as tumor suppressors, but paradoxically, they are essential for maintaining leukemic stem cells.
  • The diverse functions of FoxOs are tightly controlled by complex regulatory mechanisms.

Conclusions:

  • Understanding the precise regulation and distinct/redundant functions of FoxO proteins is essential for developing targeted therapies.
  • Modulating FoxO activity holds promise for treating cancers and other diseases where these factors play a key role.
  • Further research into FoxO regulation in physiological and pathological settings is critical.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.